Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scaffold-mediated miRNA-155 inhibition promotes regenerative macrophage polarisation leading to anti-inflammatory, angiogenic and neurogenic responses for wound healing. | Bioact Mater | 2026 | 41737641 | PubTator, text mining | PubMed |
| Regulon Reconstruction Uncovers Novel Deregulated Factors in Alzheimer's Disease. | Mol Neurobiol | 2026 | 41729360 | PubTator, text mining | PubMed |
| Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk. | medRxiv | 2026 | 41728338 | PubTator, text mining | PubMed |
| Mechanisms of resistance to bruton's tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. | Ann Hematol | 2026 | 41721839 | PubTator, text mining | PubMed |
| Ruptured Ovarian Endometrioma During Pregnancy: A Case Report and Review Highlighting Clinically Occult Risk Factors. | Cureus | 2026 | 41717148 | PubTator, text mining | PubMed |
| Epigenetics in B-CLL. | Int J Genomics | 2026 | 41716484 | PubTator, text mining | PubMed |
| Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses. | Alzheimers Dement | 2026 | 41639038 | PubTator, text mining | PubMed |
| Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer's disease risk factors. | Immunity | 2026 | 41633359 | PubTator, text mining | PubMed |
| From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs. | Alzheimers Dement | 2026 | 41618124 | PubTator, text mining | PubMed |
| COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency. | Allergy Asthma Immunol Res | 2026 | 41592542 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression. | Nat Commun | 2026 | 41559059 | PubTator, text mining | PubMed |
| SH2scan: Mapping SH2 Domain-Ligand Binding Selectivity for Inhibitors and Degraders. | J Med Chem | 2026 | 41543922 | PubTator, text mining | PubMed |
| Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review). | Oncol Rep | 2026 | 41543151 | PubTator, text mining | PubMed |
| Parkinson's disease: spatiotemporal regulation and therapeutic prospects of TREM2-mediated microglial responses. | NPJ Parkinsons Dis | 2026 | 41530159 | PubTator, text mining | PubMed |
| Next-generation Alzheimer's therapeutics: target assessment and enablement at the Indiana University School of Medicine-Purdue University TREAT-AD Center. | Alzheimers Dement | 2026 | 41527522 | PubTator, text mining | PubMed |
| Microglial phagocytosis in Alzheimer disease. | Nat Rev Neurol | 2026 | 41315858 | PubTator, text mining | PubMed |
| A national strategic framework for developing medical devices for children. | Pediatr Res | 2026 | 41254176 | PubTator, text mining | PubMed |
| High cell-type specificity of eQTLs revealed by single-nucleus analyses of brain and blood. | bioRxiv | 2025 | 41394650 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=3